Transformation Talks Agenda

6 February 2020
Dubai World Trade Centre

Day 1 - Monday, 3 February 2020

Moderator: Rachelle Ferrara, Senior Director, Global Enterprise, International Sales, Brasseler USA Surgical Instrumentation, Henry Schein Inc Company, USA 

11:00

Blockchain and medical devices: Compliance and transparency

Edward Bukstel, CEO, Clinical Blockchain, Philadelphia, Pennsylvania, USA

12:00

The future of medical reports

Baher Al Hakim, CEO, Medicus, USA

13:00

Microbiology 4.0: Re-engineering collection, processing, and analysis of Bacteriology samples

Omar Ramadan, Business Development Manager, Copan, Italy  

13:30

The world’s first universal cancer blood test for all types of cancer - Early detection

DrAhmed Bourghida, Chief Scientific Officer, RMDM limited, London, UK 

14:00

Bugs are evolving, so should diagnostics – coming soon the new BioFire® Blood Culture Identification 2 Panel

Alexander Krause, PhD., Sr. Marketing Manager, bioMérieux, France 

14:30

Genetic clinical services

Sana Islam, Commercial Applications Specialist & Genetic Counsellor, Alliance Global, Dubai, UAE 

15:00

Career talk

Educational Commission for Foreign Medical Graduates in the US

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Dr Suzanne Bakdash, Clinical Pathologist, Cleveland Clinic Ohio, Ohio, USA

Day 2 - Tuesday, 4 February 2020

Moderator: Rachelle Ferrara, Senior Director, Global Enterprise, International Sales, Brasseler USA Surgical Instrumentation, Henry Schein Inc Company, USA 

11:00

From single cell to spatial transcriptomics - 10x genomics biology at high resolution

Chiara Reggio, Channel Account Manager, EMEA, 10X Genomics, Italy

11:30

PCR|ONE: 15-minute Point-Of-Care PCR for screening and for syndromic testing

Piotr Garstecki, CEO, Curiosity Diagnostics, Poland

12:00

Updates on digital pathology

Gagan Goel, IT Director, National Reference Laboratory, Abu Dhabi, UAE

12:30

20/20 qPCR and automation

John Corbett, CEO, Biomolecular Systems, London, UK

13:00

Rapid, point of care DNA testing - a case study in precision medicine for cardiac stent patients

Riwat Lim, EU Business Lead, Spartan Bioscience, UK

14:00

Get the latest in Syndromic TRENDS – a cloud based big data initiative for epidemiology with BioFire panels

Charudutt Shah, Marketing Director (EMEA), BioFire, France

15:00

Career talk

Career ladder and progression.  Insights from Disney.

Dr Aaron Han, Consultant Pathologist and Director of Haematology and Flow Cytometry, American Hospital Dubai, Vice President, Emirates Pathology Society, Dubai, UAE

Day 3 - Wednesday, 5 February 2020

Moderator: Rachelle Ferrara, Senior Director, Global Enterprise, International Sales, Brasseler USA Surgical Instrumentation, Henry Schein Inc Company, USA 

11:00

The fastest and most comprehensive way to detect pneumonia pathogens – BioFire® Pneumonia plus Panel

Dr Basel Salama, Regional Medical Advisor – Middle East, KSA, and Caucasus, bioMérieux, UAE

11:30

The next generation of monoclonal protein measurement

James Last, Medical Science Liaison Manager, The Binding Site Group Ltd., Birmingham, UK

12:00

Updates in newborn screening & genetic disorders

Dr Ralph Fingerhut, Director, Swiss Newborn Screening Laboratory, Zurich, Switzerland

12:30

Prenatal testing: More, better, safe, effective, for all

Prof Philippos Patsalis, Founder & CEO, NIPD Genetics, Professor of Human Genetics, University of Nicosia Medical School; Distinguished Professor, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus

13:00

World of genetics

H.E. Dr. Maryam Mohd. Fatma Matar, MD, Ph.D., Founder and Chairperson, UAE Genetic Diseases Association, Dubai, UAE

14:00

Molecular solutions for the non-molecular laboratory

Dr Fawad Mansoor, Product Specialist, Randox, Dubai, UAE
Dr Scott McKeown, BDM MENA, Randox, Dubai, UAE

15:00

Career talk

My journey from university to the lab

Dr Mansour Al-Zarouni, Chair, MEDLAB Middle East Congress; Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

Day 4 - Thursday, 6 February 2020

Moderator: Rachelle Ferrara, Senior Director, Global Enterprise, International Sales, Brasseler USA Surgical Instrumentation, Henry Schein Inc Company, USA 

11:00

Rapid, point of care DNA testing - a case study in precision medicine for cardiac stent patients

Riwat Lim, EU Business Lead, Spartan Bioscience, UK

12:00

QIAstat-Dx – the next generation of syndromic insights

Henry Hatton, Professional Customer Solutions Manager, Commercial Partners, QIAStat-Dx MEA, QIAGEN, Liverpool, UK

12:30

Phenomics and the contributions of biological mass spectrometry to clinical diagnosis

Professor Ray K Iles, Founding Dean, College of Health Sciences, Abu Dhabi University, Abu Dhabi, UAE

13:00

Digital health innovation

Mazin Gadir, Strategy & Organizational Transformation Advisor, Digital Health and Innovation Consultant, Jacksonville, Florida, USA

14:00

Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow

Sonia Allibardi, Molecular Biologist, Copan Italia, Brescia, Italy